Bacterial DNA induces a proinflommatory immune response in patients with decompensoted cirrhosis
- Do Apoptotic Plasmodium- Infected Hepatocytes Initiate Protective Immune Responses? Rénia, Laurent; Maraáón, Conception; Hosmalin, Anne; Grüner, Anne Charlotte; Silvie, Olivier; Snounou, Georges // Journal of Infectious Diseases;1/1/2006, Vol. 193 Issue 1, p163
A letter to the editor is presented related to initiation of immune response by apoptotic plasmodium-infected hepatocytes.
- Immunotherapy for cancer. Johnson, Ann E. // Journal of the Royal Society of Medicine;Aug2002, Vol. 95 Issue 8, p427
A letter to the editor is presented in response to the article about the immune response that would enable to move in the devised immunotherapy for cancer in the June 2002 issue.
- Reply to Antonucci et al. Hoofnagle, Jay H.; Wahed, Abdus S.; Belle, Steven H. // Journal of Infectious Diseases;11/1/2009, Vol. 200 Issue 9, p1485
A response by Jay H. Hoofnagle, Abdus S. Wahed and Steven H. Belle to a letter to the editor about their article on the role of younger age in sustained virological response (SVR) to combination therapy for chronic hepatitis C.
- Immune response also connects autism and epilepsy. Sharma, Abhay // Nature Medicine;Aug2011, Vol. 17 Issue 8, p922
A letter to the editor is presented regarding the potential connection of immune response the pathogenesis of epilepsy and autism.
- NF-ÎºB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1Î±. Rius, Jordi; Guma, Monica; Schachtrup, Christian; Akassoglou, Katerina; Zinkernagel, Annelies S.; Nizet, Victor; Johnson, Randall S.; Haddad, Gabriel G.; Karin, Michael // Nature;6/5/2008, Vol. 453 Issue 7196, p807
The hypoxic response is an ancient stress response triggered by low ambient oxygen (O2) (ref. 1) and controlled by hypoxia-inducible transcription factor-1 (HIF-1), whose Î± subunit is rapidly degraded under normoxia but stabilized when O2-dependent prolyl hydroxylases (PHDs) that target its...
- A European perspective on immunogenicity evaluation. Schneider, Christian K; Papaluca, Marisa; Kurki, Pekka // Nature Biotechnology;Jun2009, Vol. 27 Issue 6, p507
A letter to the editor is presented in response to the article "A Risk-Based Bioanalytical Strategy for the Assessment of Antibody Immune Responses Against Biological Drugs," by G. Shankar, C. Pendley and K. E. Stein in the May 2007 issue.
- Biopeptides and immune exclusion. Khan, Sujoy // CMAJ: Canadian Medical Association Journal;1/3/2006, Vol. 174 Issue 1, p65
A letter to the editor is presented in response to several reports on the association between biologically active peptides and immune response among human beings in various 2005 issues.
- Is CD1a involved in antitumour immune responses during carcinogenesis? Cappello, F. // British Journal of Cancer;2/23/2004, Vol. 90 Issue 4, p938
Presents a letter to the editor about the role of CD1 family molecules in antitumour immune responses during carcinogenesis, published in the February 23, 2004 issue of the "British Journal of Cancer."
- Surrogate end points and their role in clinical trials: Reply from authors. Kalikar, M. V.; Thawani, V. R.; Varadpande, U. K.; Sontakke, S. D.; Singh, R. P.; Khiyani, R. K. // Indian Journal of Pharmacology;Feb2009, Vol. 41 Issue 1, p55
A response by M.V. Kalikar and associates to the letter to the editor about their article "Immunomodulatory effect of Tinospora cordiofolia extract in human immunodeficiciency virus positive patients" in the previous issue is presented.